Frequent IDH1/2 mutations in intracranial chondrosarcoma: A possible diagnostic clue for its differentiation from chordoma

Brain Tumor Pathology

Volumn 29, Issue 4, 2012, Pages 201-206

  Arai, Motohiro ^a   Nobusawa, Sumihito ^a   Ikota, Hayato ^a   Takemura, Sunao ^b   Nakazato, Yoichi ^a  

^a GUNMA UNIVERSITY   (Japan)

^b YAMAGATA UNIVERSITY   (Japan)

Author keywords

Chondrosarcoma; Chordoma; Isocitrate dehydrogenase; Mutation

Indexed keywords

GENOMIC DNA; ISOCITRATE DEHYDROGENASE 1; ISOCITRATE DEHYDROGENASE 2; DNA; IDH1 PROTEIN, HUMAN; ISOCITRATE DEHYDROGENASE; ISOCITRATE DEHYDROGENASE 2, HUMAN; PARAFFIN;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; BRAIN REGION; BRAIN TUMOR; CHONDROSARCOMA; CHORDOMA; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DNA SEQUENCE; FEMALE; GENE; GENE MUTATION; HETEROZYGOSITY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IDH1 GENE; IDH2 GENE; INTRACRANIAL CHONDROSARCOMA; MALE; MUTATIONAL ANALYSIS; TUMOR CELL; TUMOR DIAGNOSIS; CHILD; GENETICS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MUTATION; PATHOLOGY; PHYSIOLOGY;

ADULT; AGED; BRAIN NEOPLASMS; CHILD; CHONDROSARCOMA; CHORDOMA; DIAGNOSIS, DIFFERENTIAL; DNA, NEOPLASM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; ISOCITRATE DEHYDROGENASE; MALE; MIDDLE AGED; MUTATION; PARAFFIN EMBEDDING; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

EID: 84876434644     PISSN: 14337398     EISSN: 1861387X     Source Type: Journal    
DOI: 10.1007/s10014-012-0085-1     Document Type: Article

References (16)

1. Mardis ER, Ding L, Dooling DJ et al (2009) Recurring mutations found by sequencing an acute myeloid leukemia genome. N Engl J Med 361:1058-1066
2. Ohgaki H, Kleihues P (2011) Genetic profile of astrocytic and oligodendroglial gliomas. Brain Tumor Pathol 28:177-183
3. Dang L, White DW, Gross S et al (2009) Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462:739-744
4. Figueroa ME, Abdel-Wahab O, Lu C et al (2010) Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell 18:553-567
5. Amary MF, Bacsi K, Maggiani F et al (2011) IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours. J Pathol 224:334-343
6. Szuhai K, Jennes I, de Jong D et al (2011) Tiling resolution array-CGH shows that somatic mosaic deletion of the EXT gene is causative in EXT gene mutation negative multiple osteochondromas patients. Hum Mutat 32:E2036-E2049
7. Pamir MN, Ozduman K (2006) Analysis of radiological features relative to histopathology in 42 skull-base chordomas and chondrosarcomas. Eur J Radiol 58:461-470 (Pubitemid 43729055)
8. Almefty K, Pravdenkova S, Colli BO et al (2007) Chordoma and chondrosarcoma: similar, but quite different, skull base tumors. Cancer 110:2457-2467 (Pubitemid 350174931)
9. Fletcher CDM, Krishnan Unni K, Mertens F (2002) WHO classification of tumours of the soft tissues and bones. IARC Press, Lyon
10. Ohgaki H, Dessen P, Jourde B et al (2008) Genetic pathways to glioblastoma: a population-based study. Cancer Res 64:6892-6899
11. Watanabe T, Nobusawa S, Kleihues P et al (2009) IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas. Am J Pathol 174:1149-1153
12. Capper D, Weissert S, Balss J et al (2010) Characterization of R132H mutation-specific IDH1 antibody binding in brain tumors. Brain Pathol 20:245-254
13. Yan H, Parsons DW, Jin G et al (2009) IDH1 and IDH2 mutations in gliomas. N Engl J Med 360:765-773
14. Thol F, Damm F, Wagner K et al (2010) Prognostic impact of IDH2 mutations in cytogenetically normal acute myeloid leukemia. Blood 116:614-616
15. Oakley GJ, Fuhrer K, Seethala RR (2008) Brachyury, SOX-9, and podoplanin, new markers in the skull base chordoma vs chondrosarcoma differential: a tissue microarray-based comparative analysis. Mod Pathol 21:1461-1469
16. Kaneko MK, Tian W, Takano S et al (2011) Establishment of a novel monoclonal antibody SMab-1 specific for IDH1-R132S mutation. Biochem Biophys Res Commun 406:608-613